Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.
Open | $0.690 |
Close | $0.661 |
Volume / Avg. | 1.626M / 2.703M |
Day Range | 0.640 - 0.707 |
52 Wk Range | 0.199 - 3.080 |
Market Cap | $85.557M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 9.61% |
Days to Cover | 8.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atara Biotherapeutics (NASDAQ: ATRA) through any online brokerage.
Other companies in Atara Biotherapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Atara Biotherapeutics (NASDAQ: ATRA) was reported by Stifel on Monday, April 1, 2024. The analyst firm set a price target for 2.30 expecting ATRA to rise to within 12 months (a possible 220.87% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $0.7168 last updated April 19, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Atara Biotherapeutics.
Atara Biotherapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Atara Biotherapeutics.
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.